I always read the last page of a book first so that if I die before I finish I’ll know how it turned out.— Billy Crystal to Meg Ryan in “When Harry Met Sally”
This is just one of the memorable lines penned by three-time Oscar-nominated writer/director Nora Ephron. The successful movie hits included Sleepless in Seattle , When Harry Met Sally, You’ve Got Mail, and Silkwood.
She is also the author of of several books, including I Feel Bad About My Neck: And Other Thoughts On Being a Woman and Heartburn, a book written about her marriage to Bernstein
The 71-year screenwriter died of pneumonia, as a complication of acute myeloid leukemia according to her son Jacob Bernstein (his father was Ephron’s second husband Watergate reporter Carl Bernstein).
Her NY Times obituary points out that Ephron distinguished herself as “a journalist, a blogger, an essayist, a novelist, a playwright, an Oscar-nominated screenwriter and a movie director journalist, a rarity in a film industry whose directorial ranks were and continue to be dominated by men.”
Her friend, Washington Post columnist Richard Cohen, revealed that Ephron had been diagnosed with the blood disorder myelodysplasia six years ago. This is the same diagnosis ABC anchor Robin Roberts recently received.
Acute myelogenous leukemia (also called acute myeloid leukemia or AML) is a disease of the white blood cells and the bone marrow.
Cells in the bone marrow, called stem cells, can become any one of the different kinds of blood cells (see diagram below).
In AML, these stem cells become myeloid blast cells (now called leukemic cells).
They do not go on to become red blood cells, platelets or certain white blood cells of this myeloid line (cells within the blue box right).
This can lead to:
Symptoms of leukemia include:
Treatment options include chemotherapy, biological therapy, radiation therapy, bone marrow (or stem cell) transplant, as well as new and innovative treatments that are beginning to be used.
For more information:
Resounding Health(tm) Acute Myeloid Leukemia |
0 comments